IMVT   $29.47  -0.47% Market Open

Immunovant Inc
Total Cash 560.00M
totalCashPerShare 3.826
EBITDA -298.26M
Total Debt 69.00K
quickRatio 12.493
currentRatio 13.085
Total Revenue
debtToEquity 0.013
Revenue/Share
ROA -0.39658
ROE -0.64545
grossProfits
freeCashflow -157.40M
operatingCashflow -243.06M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 3.78B
forwardPE -11.4440155
floatShares 65.29M
sharesOutstanding 146.37M
sharesShort 12.39M
sharesShortPriorMonth 11.21M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.56%
heldPercentInstitutions 0.52%
Short Ratio help_outline 16.14%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue 3.726
Price To Book help_outline 7.95
earningsQuarterlyGrowth
netIncomeToCommon -272.55M
trailingEps -1.91%
forwardEps -2.59%
enterpriseToEbitda -12.68
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.6 3Q 2024
institutionsCount 280
lastUpdated Sept. 16, 2024, 7:55 p.m.